321 results
Page 4 of 17
424B5
tlvvx48wega28
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
hpsja1ft2qfr3oy9g
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
8-K
EX-1.1
m9w1ynnutrrzdz
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
8-K
EX-99.2
cdw3 88vli2ywsbo8
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
8-K
EX-99.1
qjxyqdqq jy
28 Jan 21
Updated Summary Business Information
4:26pm
424B5
0d3 1es4e
28 Jan 21
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
olbxo9uoqpyulo5ydj7m
26 Jan 21
Adamis Pharmaceuticals Provides Update On Its US Compounding Business
9:17am
8-K
EX-99.1
nvqaa9o6
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
8-K
EX-99.2
le1 zo3va3
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
424B5
kv865mrem0ns1cpq0hkf
21 Sep 20
Prospectus supplement for primary offering
6:03am
8-K
EX-1.1
7j4d8r71
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
8-K
EX-99.2
q3ottztu1l
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
8-K
ri07j 9z9c7tv
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
424B5
d8re884
17 Sep 20
Prospectus supplement for primary offering
4:22pm
8-K
EX-10.1
aqfg5t92rcg
24 Aug 20
Departure of Directors or Certain Officers
4:36pm